To support the chemistry, manufacturing and control (CMC) and preclinical development of an inactivated rotavirus vaccine.

To support key laboratory systems strengthening interventions for early disease detection, disease monitoring, and laboratory based disease surveillance for priority diseases of public health importance in Lagos, Nigeria.

To increase vaccine confidence and access among those most affected by mpox.

To support CDC with diagnostic development and processing for the global Guinea Worm Eradication Program (GWEP). This project will provide CDC with the laboratory support needed to diagnose possible Guinea worm (GW) specimens submitted by endemic and non-endemic countries and to validate and/or develop novel Guinea worm diagnostic tests.

To provide project management services to include management of design and performance by CDC of an animal research study involving application of microarray patches (MAPs) containing antiretrovirals for HIV treatment to rhesus macaques.

To provide support to CDC, working toward the elimination of healthcare-associated infections in all medical care settings.

To provide travel support for onsite technical assistance to countries conducting various rotavirus studies.

To complete the Zika Contraceptive Access Network (Z-CAN) through data collection, evaluation and dissemination.

To enable veterinary students from across the United States, Canada and the Caribbean to learn more about opportunities in public health for veterinary professionals.

To support key initiatives addressing typhoid and cholera including the evaluation manuscript of the pilots of the Burden and Risk Assessment in Typhoid (BRAT) framework, the implementation of the BRAT tool in real-world settings and the development of a manuscript on vaccination strategies in conflict settings.

To show the health impact of low-cost, Indian-made rotavirus vaccines in high burden, low-income countries of Africa and Asia.

To conduct an evaluation before and two years after the introduction of the Pneumococcal conjugate vaccine (PCV) to study the direct and indirect impact of PCV introduction on vaccine-type pneumococcal carriage among healthy Indonesian children under five years of age.

To assist the Ministry of Public Health (MOPH) in establishing a Field Epidemiology Training Program (FETP) in Qatar focused on building its public health workforce capacity.

To evaluate the impact of HPV vaccine and the persistence of HPV antibody among HPV-vaccinated women living with HIV in Botswana.

To engage partners and stakeholders on awareness and education for infection associated chronic conditions (IACC).

To engage communities through the power of arts and culture to educate, empower and mobilize individuals toward positive change. Thriving Together Atlanta serves as a model of how cross-sector partnerships can address multifaceted issues affecting communities today.

To build community resilience against weather events by supporting local disaster preparedness programs through community-based organizations in the Midwest, with a focus on rural areas.

To support the production and qualification of inactivated rotavirus vaccine clinical material.

To promote safety and wellness among U.S. travelers through the collection and dissemination of up-to-date and accurate scientific information.

To support two annual two-day conferences for journalists from media outlets reaching rural, frontier and urban populations to provide training on where to access reliable health information.

To honor and recognize important work to promote safe injection practices and patient safety and produce educational materials that raise awareness and highlight the work of the One & Only Campaign.

To support Haiti's vaccine distribution efforts as well as water and sanitation improvements in response to the 2021 earthquake.

To evaluate the impact of a pneumococcal conjugate vaccine schedule change in Mozambique on vaccine-type pneumococcal carriage and invasive pneumococcal disease; and serotype 1 colonization among patients with suspected pneumonia and serotype 1 disease among children and adults.

To improve awareness and implementation of respiratory virus prevention, the CDC Foundation will support a coalition that shares information, promotes collaboration and advances CDC goals to strengthen coordination and data-informed strategies.

To provide laboratory support for the analysis of immunogenicity and shedding of new oral Poliovirus vaccines in human clinical trials and related issues for polio endgame.

To assess the impact of the Pneumococcal conjugate vaccine catch up campaign among internally displaced populations in the northern Sahel region of Burkina Faso. This effort will implement and evaluate the impact of changing the pneumococcal conjugate vaccine schedule.

To develop cell culture and small animal models of Nipah virus replication and pathogenesis in a biosafety level (BSL) 4 lab.

To investigate long-acting PrEP formulations in macaque subjects.

To continue to increase health security in countries by improving their capacity and expanding support using new and more relevant tools of the National Action Plan for Health Security (NAPHS) Toolkit in at least six countries.